Management strategies for common viral infections in pediatric renal transplant recipients

Table 4 Prevention of viral infections kidney transplant recipients

CMV	Valganciclovir
	Universal prophylaxis - Dose (mg) = (7 × BSA × eGFR) once a day
	Preemptive therapy - Dose (mg) = ( 7 × BSA × eGFR) bd
EBV	EBV viral load surveillance and preemptive therapy for EBV mismatched patients
BKPyV	BK viral load monitoring and early identification of BK viremia
HSV	Avoidance of visitors or health professionals who have HSV signs and symptoms
VZV	Avoidance of visitors or health professionals who have VZV signs and symptoms. Vaccination including family members
Hepatitis B & C	Hepatitis B vaccination and immunity verified with Hepatitis B surface antibody screening following completion of the vaccination series
Respiratory viruses	Avoidance of other individuals who have signs or symptoms of infection, hand hygiene, and use of droplet precautions for those suspected of having infection

CMV: Cytomegalovirus; EBV: Epstein-Barr virus; BKPyV: Human BK polyomavirus; HSV: Herpes simplex viruses; VZV: Varicella zoster virus.